Gold Social Responsible Corporate (SRB)
100.000US$Gold Social Responsible Corporate (SRB) memberVálido por 12 mesesCorporate (CSA/SRB) member
5000US$Válido por 12 mesesIndividual Corporate (SRB) member
2500US$Válido por 12 mesesClassic Community Corporate (SRB)
50.000US$Classic Community Corporate (SRB) memberVálido por 12 mesesPlatinum Signature Sponsor for ESG
150.000US$Válido por 12 mesesDiamond Lead Sponsorship
200.000US$Diamond Lead Sponsor for Health Equity, Sustainability and Governance.Válido por 12 mesesCommunity Leadership Corporate member
10.000US$Válido por 12 mesesSilver Social Responsible Corporate
75.000US$Silver Social Responsible Corporate (SRB) memberVálido por 12 meses
Our Programs
Public Education Outreach
Global Health Initiative 2030 public outreach aims to bring knowledge awareness campaign to reach the public with illicit drugs analytical report, regional drug accessible by individuals, Precinct and DEC alike. Know-Drugs.us and Know-Drugs.app aims to reach individuals with practitioners, institutions for Opioid Use Disorder/Substance Use Disorder (OUD/SUD) treatment support.
The individualized interactive guidance to the practitioners and institution engaged in OUD/SUD therapies leading in diverse healing modalities with tools and Medical Rehabilitation.
​
Global Health Initiative 2030 public outreach aims to bring knowledge awareness campaign to reach the public with the purpose bring AI/ML/VL driven scientific data to collect, review, report, and publish laboratory and scientific testing results from certified laboratories for public accessibility and republish data from our partnering organization's analytical data projects worldwide.
​
Our goal is to bring illicit dangerous drugs' analytical report, and present safety issues of the regionally accessible drugs by individuals.
​
Know-Drugs.us and Know-Drugs.app aims to reach laboratory technicians and first responders, connect them to regional practitioners, and institutions for diverse mental health and Opioid Use Disorder/Substance Use Disorder (OUD/SUD) treatment support. The individualized interactive guidance to the practitioners and institution engaged in OUD/SUD therapies leading in diverse healing modalities with tools and Recovery and Medical Rehabilitation.
Practitioner Training
KRFI in collaboration with SAHMSA, aims to bring
trainings for practitioners in working with OUD/SUD locally with Clinical Treatment Applications (CTA) protocols, and training for integrated lab analysis of biomarkers through the big data management, guided protocol use of Ibogaine and psychedelic treatments.
​
Clinical protocol partners with social equity research programs of Psychedelics (Psilocybin, Medical Cannabis, and other), as entheogenic medicines for PTSD, Trauma and Depression for veterans, and individuals. The OUD/SUD treatments seek to develop and utilize a patient base mental health therapeutics database in conjunction to HIPPA and EHRs guidelines.
Concepts
Global Health Initiative 2030 aims to bring partnership to the regional level through in-country coordinating mechanism (CCM) with WHO Pre-qualification Partners to join Drug Supply Chain Security Act (DSCSA) Blockchain platform to bring pharmaceutical GMP security to support action to impact regional drug policy coalition with Opiate/Opioid GMP manufacturers for QA/QC, global health drug security policy adaption.
Key Technologies
Global Health Initiative 2030 aims to implement technologies in partnerships for awareness, campaigns, and efficient security platforms.
Know-Drugs App
KRFI Know-Drug.app is free and public benefit program to provide the public access to substance tracing through public support for analytical report information. KRFI Global Health Initiative 2030 public outreach program aims to bring knowledge awareness campaigns to inform the public about harm-reduction and support-seeking medical practitioners, personnel, and researchers. Public access to illicit drugs and their analytical report, regional drug accessible by individuals, Precinct and Department of Environmental Control (DEC) alike to be able to respond appropriately to public policies and emergency medical responses. Know-Drugs.us and Know-Drugs.App aims to reach individuals with practitioners, and institutions for OUD/SUD treatment support. Know-Drug.Org is a partnership with European partners to identify a way to reduce the harm from drug consumption by allowing users to know the content and the variety and identity of adulterants of substances around the world. The App aims to empower users to make safer choices: to avoid dangerous substances and its dangerous combinations.
Questors: CTMS Blockchain
KRFI's Questors: Clinical Trial Management Platform is a blockchain to serve the Ibogaine Clinical Trials in partnership with Global Health Initiatives 2030 for building a safe environment and harm reduction by support and provision for partnership for GMP clinical trial supplies, double blind studies, by our global partners engaged in regional clinical studies. KRFI assists as an open source for preclinical and clinical protocols in combating addiction and OUD/SUD protocols, and brining clinical trials for safe use of Psychedelic & Entheogenic natural products medicines for diverse indications of PTSD, Trauma, and others. The Questors: Clinical Trial Management Platform blockchain technology, is a dependable tool that is suited for the purposes of Clinical Trial Application with comprehensive support for the CRO support, Pre-Clinical archival data, providing reliable clinical data to advance new medical treatments for the indications by mutual data sharing, collection, preservation, and accessibility.
Drug Supply Chain Security Act (DSCSA Blockchain)
FDA’s Drug Supply Chain Security Act (2013) FDA is working with the selected participants to explore and evaluate methods to enhance the safety and security of the drug supply chain. DSCSA is a law to be implemented by 2023 as a Blockchain to drug supply chain stakeholders, all US GMP manufacturer to distributors are developing the serialization, interoperable system that secures production to be traceable to the consumers.
Under the DSCSA Blockchain program, FDA and global compliance with regulatory requirements or an endorsement of a particular technology, system, or other approach used in the pilots reflect the diversity of the supply chain including large and small entities from all industry sectors to safeguard the future of healthcare, manufacturers in the supply chain. KRFI aims to implement Questors: DSCSA Blockchain to partner nationally, to identify and trace the Opiate, Opioid, controlled substances manufacturers globally for fake medicine and prescription drugs that are distributed illegally within the United States. DSCSA Blockchain serves as a validation program of Seeds to Products, which supports the regional Drug Policy countries joining in this global health initiative.
.webp)
KRFI aims to stem the tide of opioid overdose deaths and addiction, by bringing transparency to the entire drug supply chain ecosystem.
About KRFI
KRFI was launched in 1989 by MyungHi Sonserai Lee to conserve and protect indigenous knowledge of medicinal plants for the advancement of the treatment of neglected diseases around the world.
KRFI is scientifically informed practice to policy, by evidence-based research, challenge reform, build policy coalition to prevent overdose deaths by prevention and Opioid Use Disorder/Substance Use Disorder (OUD/SUD) chemical dependence with the discover, developer and deliver of mental health Ibogaine and Psychedelics for addiction treatments. We have been committed to the development and research of traditional plant medicines for healing applications since 1986. Our contribution to the Access for Benefit Sharing -IP has established number of global policy initiatives for Malaria (ACT Rollback Malaria 2004) and has developed a Drug Master File for botanical drug for diverse products including Ibogaine. KRFI plans to develop through to the FDA Ibogaine clinical trial stage develpment.
KRFI develops traditional medicines and practices by securing intellectual property and land rights for the people and lands that originally provided medicine and knowledge. Biodiversity, sustainable sourcing, intellectual property protections, and access and benefit sharing are the tenets that inform our partnerships and product development. Our Research and Educational program develop the protection of the indigenous right to IP, and medical relief, in the present cultural context of the integrative health practices of entheogenic medicine.
Licensed and taxed drug distribution systems are less violent, less expensive, and more effective than prohibition.
Knowledge Recovery Foundation / Institute
Neglected Diseases Clinical Trials Research & Drug Policy Coalition
Our Programs
Public Education Outreach
Global Health Initiative 2030 public outreach aims to bring knowledge awareness campaign to reach the public with illicit drugs analytical report, regional drug accessible by individuals, Precinct and DEA alike. Know-Drugs.us and Know-Drugs.app aims to reach individuals with educational Drug Drug interactions, Pharmacovigilance research and reporting platform for first 988 responders, laboratory technicians, practitioners, institutions for Opioid Use Disorder/Substance Use Disorder (OUD/SUD) treatment support.
The individualized interactive guidance to the scientist, researchers, and practitioners and institution engaged in OUD/SUD and mental health therapeutics and therapy program leading in diverse integrative medicine and healing modalities with Medically Assisted Rehabilitation.
Ibogaine & Psychedelics Clinical Trials
The Questors: Global Health Clinical Trial Management System (CTMS) works globally with CRO partners with Ibogaine use for OUD/SUD therapeutics in diverse indications. Natural Products Psychedelics (Ibogaine, 5 Meo-DMT, DMT, Psilocybin, Ayahuasca, Medical Cannabis, and other) entheogenic medicines for Addiction, Trauma and Depression aims to share the Clincial Trial Alliance in a hyperledger as a tools to advance the current scientific progress. The Questors: Global Health CTMS aims to partner Ibogaine treatments for OUD/SUD in US FDA and global Clinical Trial regulatory agencies as partnership for a regional trial.
Concepts
Global Health Initiative 2030 aims to bring partnership to the regional level through in-country coordinating mechanism (CCM) with WHO Pre-qualification Partners to join Drug Supply Chain Security Act (DSCSA) Hyperledger platform to bring Biopharmaceutical GMP security to support action to impact regional drug policy coalition with Opiate/Opioid GMP manufacturers for QA/QC, Global Mental Health Food and Drug Security Policy adaption. UNCBD has adopted Private Public Sector Partnership for Access for Benefit Sharing with diverse countries globally for ABS-IP registry. KRFI Questors ABS-IP Hyperledger Track and Trraces to accredits Bidoversity and Carbon Credits to the our offset partners for our partner at the Global Mental Health Security Fund.
Practitioner Training
KRFI in collaboration with NYS Commission for Office of Addiction Social Services (OASAS) and American Society Addiction Medicine (ASAM), and National Center on Addiction and Substance Abuse to bring trainings for practitioners in working with OUD/SUD locally with Clinical Treatment Applications (CTA) protocols, and training modules for integrated lab analysis of biomarkers through the big data real time research management, guided protocol use of Ibogaine and psychedelic treatments and mental health products.
Clinical protocol partners with social equity research programs of Psychedelics (Psilocybin, Medical Cannabis, and other), as entheogenic medicines for PTSD, Trauma and Depression for veterans, and individuals. The OUD/SUD treatments seek to develop and utilize a patient base mental health therapeutics database in conjunction to HIPPA and EHRs guidelines.